Regeneus Ltd. appointed Leo Lee as an independent nonexecutive director.
Lee is president at Merck Serono, Japan, and previously served as president of Allergan, Japan.
Regeneus appoints nonexecutive director
A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research
2021 Year in Review: Highlighting Key Investment Banking Trends
Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings
Global M&A By the Numbers: Q3 2021
Regeneus Ltd. appointed Leo Lee as an independent nonexecutive director.
Lee is president at Merck Serono, Japan, and previously served as president of Allergan, Japan.